PATRIOT ACT TARGETS OTC MEDICATIONS

APRIL 01, 2006

Individuals wanting OTC pseudoephedrine (PSE) products are going to be limited as to the number of pills they can buy, and eventually they will have to show identification to purchase these types of medication. The provision is part of President George W. Bush's USA Patriot Act in an attempt to crack down on illegal methamphetamine production.

Beginning this month, federal regulation will limit the sale of PSE to 9 g within a 30-day period. The measure will make exceptions for "single-use" sales—individually packaged PSE products. Identification checks and PSE products located behind the counter will be required by September 30, 2006.

Many retailers already have guidelines in place to limit individuals' access to cold products or to limit their sales. Some drugmakers also have begun making PSE-free cough and cold products.




SHARE THIS SHARE THIS
0

Conference Coverage

Check back here regularly for live conference coverage from the American Academy of Pain Medicine and the upcoming American Pharmacists Association Meeting and Expo. 


Pharmacy Times Strategic Alliance
 

Pharmacist Education
Clinical features with downloadable PDFs


Next-Generation Pharmacist® Awards


3rd Annual Convenient Healthcare and Pharmacy Collaborative Conference


SIGN UP FOR THE PHARMACY TIMES NEWSLETTER
Personalize the information you receive by selecting targeted content and special offers.